Cardiomyopathy Clinical Trials

Find Cardiomyopathy Clinical Trials Near You

Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 1/Phase 2
SUMMARY

The purpose of this study is to conduct clinical research on \[68Ga\] Ga-NI-FAPI-04 PET/CT imaging and further investigate its diagnostic value in fibroblast activation related diseases.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 85
Healthy Volunteers: t
View:

• 1: 18-85 years old

• 2: Tumor patients can undergo surgery or biopsy to obtain pathological diagnosis

• 3: Ability to understand and sign informed consent forms

• 4: Expected survival period exceeding 6 months and able to receive follow-up

• 5: Healthy volunteers without chronic medical history of hypertension, diabetes, coronary heart disease, kidney disease, tumor, etc

Locations
Other Locations
China
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
RECRUITING
Beijing
Contact Information
Primary
Zhu
yfwyw1999@126.com
+86-13021115973
Time Frame
Start Date: 2025-12-17
Estimated Completion Date: 2027-06-17
Participants
Target number of participants: 30
Treatments
Experimental: NI-FAPI group
Injection of \[68Ga\]Ga-NI-FAPI
Sponsors
Leads: Peking Union Medical College Hospital

This content was sourced from clinicaltrials.gov

Similar Clinical Trials

We couldn't find any related articles check for more on the main search page.